Keywords: aventis, immunogen, sign, deal, develop, anticancer, therapies

Aventis and ImmunoGen sign deal to develop anticancer therapies

Article | 04 August 2003

Print This

Aventis and ImmunoGen have entered into an agreement to develop novel antibody-based cancer therapies. Under the deal, Aventis will obtain ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in